摘要
目的分析获得性急性肾衰竭（HAHARF）的易患因素及血液透析治疗对其预后的影响，以提高HA-ARF的疗效。方法回顾分析在我院诊治的82例HA-ARF患者，与同期的社区获得性ARF（CA-ARF）患者进行对比。结果82例HA-ARF患者中，药物所致45例（54．9％）、肾脏低灌注12例（14．6％）、感染11例（13．4％）、手术后10例（12．2％）、肾后梗阻3例（3．7％）、产后1例（1．2％）。经血液透析及原发病治疗，31例肾功能完全恢复（37．8％），95例CA-ARF患者肾功能完全恢复（49．7％），HA-ARF组中行血液透析治疗比未行血液透析治疗治愈率高（P〈0．05）。结论HA-ARF以药物所致为主，病情重、变化快；与CA-ARF组比较，血液透析治疗效果差，治愈率低（P〈0．01）；治疗上应以预防为主，早期积极血液透析治疗可降低死亡率。
Objective To investigate the risk factors of hospital-acquired acute renal failure （HA-ARF） and the prognosis of patients who had subjected to hemodialysis in order to promote the therapeutic results of HA-ARF. Method Retrospective analysis was performed on 82 patients with HA-ARF, among them 42 patients had been treated with hemodialysis, and compared with the patients with community-acquired acute renal failure （CA-ARF）at the same period. Results Among the 82 patients with HA-ARF, drugs, low renal perfusion, infections, operations, post renal obstruction, post partum accounted for（45）54. 9%,（12）14. 6%,（11）13.4%,（10）12. 2%,（3）3.7%,（1）1.2% respectively after received treatment for original diseases and hemodialysis, 31 patients （37. 8 %） of the HA-ARF group achieved complete remission, 95 patients （49. 7% ） of the CA-ARF group obtained complete remission, The cure rate of the patients who were treated with hemodialysis higher than those not treated by hemodialysis in HA-ARF group （P〈0. 05）. Conclusions The major cause of HA-ARF are drugs, the clinical manifestations of HA-ARF patients are complicated and change rapidly. The therapeutic result in the HA-ARF group is poor than that in the CA-ARF group（P〈0. 01）. The cure rate of the patients in the HA-ARF group is lower than that in the CA-ARF group（P〈0. 01）. Prevention is the primary strategy, immediate and proper purification according to the disease state may reduce the mortality.
出处
《临床肾脏病杂志》
2007年第2期51-52,共2页
Journal Of Clinical Nephrology
关键词
肾衰竭
急性
获得性
病因
血液透析
预后
Renal failure, acute, acquired
Etiology
Hemodialysis
Prognosis
